Compare Mesoblast Limited (MESO) vs Ferrari NV (RACE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Ferrari NV — how do they compare? Mesoblast Limited trades at $16.96 (market cap $2.21B), while Ferrari NV trades at $409.2 (market cap $71.67B). The key difference: Ferrari NV is far larger — about 32.4× Mesoblast Limited's market cap, and Ferrari NV pays a 1.04% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MESO | RACE | |
|---|---|---|
Market Cap | $2.21B | $71.67B |
Sector | Technology | Consumer Cyclical |
52-Week High | $20.96 | $504.09 |
52-Week Low | $12.88 | $314.63 |
Enterprise Value | $2.21B | $73.60B |
Dividend Yield | — | 1.04% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Ferrari NV
Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.
Read more on RACE →
